169 related articles for article (PubMed ID: 27659780)
1. To gate or not to gate - dosimetric evaluation comparing Gated vs. ITV-based methodologies in stereotactic ablative body radiotherapy (SABR) treatment of lung cancer.
Kim J; Wu Q; Zhao B; Wen N; Ajlouni M; Movsas B; Chetty IJ
Radiat Oncol; 2016 Sep; 11(1):125. PubMed ID: 27659780
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
3. Technical Note: Dosimetric evaluation of Monte Carlo algorithm in iPlan for stereotactic ablative body radiotherapy (SABR) for lung cancer patients using RTOG 0813 parameters.
Pokhrel D; Badkul R; Jiang H; Kumar P; Wang F
J Appl Clin Med Phys; 2015 Jan; 16(1):5058. PubMed ID: 25679161
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric analysis of respiratory-gated radiotherapy for hepatocellular carcinoma.
Xi M; Zhang L; Liu MZ; Deng XW; Huang XY; Liu H
Med Dosim; 2011; 36(2):213-8. PubMed ID: 20570128
[TBL] [Abstract][Full Text] [Related]
5. Image-guided respiratory-gated lung stereotactic body radiotherapy: which target definition is optimal?
Zhao B; Yang Y; Li T; Li X; Heron DE; Huq MS
Med Phys; 2009 Jun; 36(6):2248-57. PubMed ID: 19610314
[TBL] [Abstract][Full Text] [Related]
6. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
7. A planning study investigating dual-gated volumetric arc stereotactic treatment of primary renal cell carcinoma.
Devereux T; Pham D; Kron T; Foroudi F; Supple J; Siva S
Med Dosim; 2015; 40(1):82-8. PubMed ID: 25498837
[TBL] [Abstract][Full Text] [Related]
8. MLC tracking for lung SABR reduces planning target volumes and dose to organs at risk.
Caillet V; Keall PJ; Colvill E; Hardcastle N; O'Brien R; Szymura K; Booth JT
Radiother Oncol; 2017 Jul; 124(1):18-24. PubMed ID: 28655454
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric Consequences of 3D Versus 4D PET/CT for Target Delineation of Lung Stereotactic Radiotherapy.
Siva S; Chesson B; Callahan JW; Hardcastle N; Crawford L; Antippa P; Wright G; MacManus MP; Hicks RJ; Kron T; Ball DL
J Thorac Oncol; 2015 Jul; 10(7):1112-5. PubMed ID: 26134229
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric selection for helical tomotherapy based stereotactic ablative radiotherapy for early-stage non-small cell lung cancer or lung metastases.
Chi A; Liao Z; Nguyen NP; Xu J; Welsh JS; Jang SY; Howe C; Komaki R
PLoS One; 2012; 7(4):e35809. PubMed ID: 22558228
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
[TBL] [Abstract][Full Text] [Related]
12. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
[TBL] [Abstract][Full Text] [Related]
13. A comparative planning study for lung SABR between tri-Co-60 magnetic resonance image guided radiation therapy system and volumetric modulated arc therapy.
Park JM; Park SY; Kim HJ; Wu HG; Carlson J; Kim JI
Radiother Oncol; 2016 Aug; 120(2):279-85. PubMed ID: 27401404
[TBL] [Abstract][Full Text] [Related]
14. Robust optimization in lung treatment plans accounting for geometric uncertainty.
Zhang X; Rong Y; Morrill S; Fang J; Narayanasamy G; Galhardo E; Maraboyina S; Croft C; Xia F; Penagaricano J
J Appl Clin Med Phys; 2018 May; 19(3):19-26. PubMed ID: 29524301
[TBL] [Abstract][Full Text] [Related]
15. Analysis of suitable prescribed isodose line fitting to planning target volume in stereotactic body radiotherapy using dynamic conformal multiple arc therapy.
Oku Y; Takeda A; Kunieda E; Sudo Y; Oooka Y; Aoki Y; Shimouchi Y; Nishina R; Nomura K; Sugiura M; Ohashi T
Pract Radiat Oncol; 2012; 2(1):46-53. PubMed ID: 24674036
[TBL] [Abstract][Full Text] [Related]
16. The development of a 4D treatment planning methodology to simulate the tracking of central lung tumors in an MRI-linac.
Al-Ward SM; Kim A; McCann C; Ruschin M; Cheung P; Sahgal A; Keller BM
J Appl Clin Med Phys; 2018 Jan; 19(1):145-155. PubMed ID: 29194940
[TBL] [Abstract][Full Text] [Related]
17. A technique of using gated-CT images to determine internal target volume (ITV) for fractionated stereotactic lung radiotherapy.
Jin JY; Ajlouni M; Chen Q; Yin FF; Movsas B
Radiother Oncol; 2006 Feb; 78(2):177-84. PubMed ID: 16376444
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Various Dose Normalization Strategies When Implementing Linear Boltzmann Transport Equation Dose Calculation for Lung Stereotactic Body Radiation Therapy Planning.
Erickson BG; Ackerson BG; Kelsey CR; Yin FF; Adamson J; Cui Y
Pract Radiat Oncol; 2022; 12(5):446-456. PubMed ID: 35219882
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiotherapy of intrapulmonary lesions: comparison of different dose calculation algorithms for Oncentra MasterPlan®.
Troeller A; Garny S; Pachmann S; Kantz S; Gerum S; Manapov F; Ganswindt U; Belka C; Söhn M
Radiat Oncol; 2015 Feb; 10():51. PubMed ID: 25888786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
